绍兴京新药业有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 民营公司 Size: 500-999人 Founded: 22年
Industry: 制药/生物工程
Full name: 绍兴京新药业有限公司。

Development Stage

Ranking: Ranked #18 in 杭州医药原料药公司 by popularity Ranked #24 in 杭州原料药公司 by popularity Ranked #59 in 杭州医药科技公司 by popularity Ranked #64 in 杭州原料公司 by popularity
Honors: 驰名商标名牌产品 According to algorithm
Salary: 76.2% of positions earn 6-10K, In 2026 vs last yeardecreased by 32%.。Master's salary: ¥12.5K.
Recruiting: In 2026 vs 2025decreased by 48%.
Requirement: Education: 本科 leads with 66.7%. Experience: 不限 leads with 81%.
Region: Distributed across 1 regions, 绍兴: 90.5%, 杭州: 9.5%.

About the Company

上虞京新药业有限公司系浙江京新药业股份有限公司全资控股分子公司，浙江京新药业股份有限公司是中国制药百强企业，医药上市公司。公司产品以生产原料药（左氧氟沙星系列、加替沙星系列、环丙沙星系列、氯雷他定、辛伐他汀、盐酸舍曲林、氧氟沙星等）为主，是国内*大的喹诺酮类原料药生产基地之一。公司已全面通过国家GMP认证，ISO14001认证，辛伐他汀已获得COS证书，盐酸环丙沙星已获得COS证书、法国GMP证书、欧盟GMP证书、KFDA注册证书。公司多次荣获省市级的荣誉称号；"京新"商标是浙江省*商标、中国驰名商标，"京新药业"被评为浙江省知名商号； "辛伐他汀"等产品是浙江名牌产品；"左氟羧酸"、"氯雷他定及制剂"、"甲磺酸加替沙星及其制剂"等多个产品被列为国家火炬计划项目，"盐酸舍曲林"项目被列入国家生物医药高技术产业化示范项目

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (10 open positions)

Manage

Growth Rate

2026 vs 2025

2025: Up 283%
2024: Down 83%
2023: Up 3500%
2022: Flat 0%-

Year-by-Year Hiring:

2021 1 jobs 2022 1 jobs 2023 36 jobs 2024 6 jobs 2025 23 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

Shaoxing 9 Hangzhou 1

Latest Jobs

Note: How fast is hiring at 绍兴京新药业有限公司 growing? 2025: 23 openings (up 283%), 2024: 6 openings (down 83%), 2023: 36 openings (up 3500%), 2022: 1 openings (flat), 2021: 1 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)

N/A

Growth Rate

Master's Hiring by Year: 2025

2023 1 jobs 2025 2 jobs

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Master's Salary 򀀩

How fast is master's hiring at 绍兴京新药业有限公司 growing? Master's recruitment over the years: 2025: 2 openings (up 283%), 2023: 1 openings (up 3500%).

— What Are the Salaries Like? (21 records)

Manage

Salary Overview

￥6-10K

76.2% of roles pay

salary range: 3K - 30K, 76.2% of roles pay ￥6-10K

4.8% 3-4.5K ***  ? 6-8K ***  ? 8-10K 4.8% 10-15K 9.5% 15-20K 4.8% 20-30K

Note: salary statistics are based on 21 salary records from the past year and depend on the job sample. For reference only.

Salary Ranking

By Category

工厂生产类￥7.9K  生物/制药/化工/环保类  在校学生类  技工类  机械/仪器仪表类 

How is the salary at 绍兴京新药业有限公司?76.2% of positions earn 6-10K, Undergraduate salary: ¥。工厂生产类 average salary ¥7.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)

Are salaries high at 绍兴京新药业有限公司? We provide: 生产技术，cs，qa，人事，保安，内贸，化工操作，司机，合成技术员，安全，安装，实习生，招生，操作员，机修，检验，环保，研究员，药品注册，行政. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

工厂生产类
38.1% of total 38.1%
生物/制药/化工/环保类
19% of total 19%
在校学生类
14.3% of total 14.3%
技工类
14.3% of total 14.3%

Job Location

Education

本科
66.7% of total 66.7%
高中
14.3% of total 14.3%
大专
14.3% of total 14.3%
硕士
4.8% of total 4.8%

Experience

不限
81% of total 81%
3-5年
14.3% of total 14.3%
5-10年
4.8% of total 4.8%

View Detailed Analysis

What does 绍兴京新药业有限公司 require? Who is 绍兴京新药业有限公司 hiring? recruitment: 工厂生产类占比最多占38.1%，其次是生物/制药/化工/环保类占19%. What education can get in at ? 本科占比最多占66.7%，其次是高中占14.3%. High education required at ? 硕士占4.8%. Work experience required at ? 不限占比最多占81%，其次是3-5年占14.3%. Where are the job locations at ? 绍兴占比最多占90.5%，其次是杭州占9.5%. Based on job postings from the past year, for reference only.